Avantor Inc (NYSE:AVTR)
$ 24.93 -0.28 (-1.11%) Market Cap: 16.93 Bil Enterprise Value: 22.16 Bil PE Ratio: 65.61 PB Ratio: 3.17 GF Score: 77/100

Avantor Inc at Morgan Stanley Healthcare Conference Transcript

Sep 10, 2019 / 08:05PM GMT
Release Date Price: $15.56 (-4.25%)
David Horn;Managing Director

Great. Well, thanks. My name is David Horn with Morgan Stanley. Thanks for attending the Avantor presentation. I would first point you to the important disclosures on our website at morganstanley.com/researchdisclosures for any statements and forward-looking comments that may be made here today. So please take a look at that.

Very excited today to have with me Michael Stubblefield, President and CEO of Avantor; and Tom Szlosek, EVP and CFO of Avantor.

So we'll dive right into it and maybe start with you, Michael, just in terms of -- for those folks who may not be as familiar with Avantor, maybe just a quick few minutes on background and overview of the company would be helpful.

Michael Stubblefield
Avantor, Inc. - President, CEO & Director

Yes. No, I think that's a great place to start. And firstly, thanks for having us, and thanks for joining us here in the room today. Excited to be here and talk about our business.

Avantor, as we sit here today, is a relatively new story for most of you

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot